| Trial ID: | L0864 |
| Source ID: | NCT02568787
|
| Associated Drug: |
RBAC
|
| Title: |
The Effect of an Enhanced Rice Bran Nutritional Supplement on Non-Alcoholic Fatty Liver Disease (NAFLD)
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-Alcoholic Fatty Liver Disease;Non-Alcoholic Fatty Liver Disease;Non-Alcoholic Fatty Liver Disease;Non-Alcoholic Fatty Liver Disease
|
| Interventions: |
Dietary Supplement: rice bran arabinoxylan compound (RBAC);Dietary Supplement: Placebo;Dietary Supplement: rice bran arabinoxylan compound (RBAC);Dietary Supplement: Placebo;Dietary Supplement: rice bran arabinoxylan compound (RBAC);Dietary Supplement: Pl
|
| Outcome Measures: |
Change from baseline in liver function test;Change from baseline in metabolic markers;Change from baseline in immunological markers;Change from baseline in liver function test;Change from baseline in metabolic markers;Change from baseline in immunological markers;Change from baseline in liver function test;Change from baseline in metabolic markers;Change from baseline in immunological markersChange from baseline in systolic blood pressure;Change from baseline in Diastolic blood pressure;Pulse;Change from Baseline in Quality of Life
|
| Sponsor/Collaborators: |
University of Miami
|
| Gender: |
All
|
| Age: |
18 Yearsnan
|
| Phases: |
Not applicable
|
| Enrollment: |
23
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
|
| Start Date: |
01/10/2015
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
16 December 2017
|
| Locations: |
United States;United States;United States;United States;United States
|
| URL: |
https://clinicaltrials.gov/show/NCT02568787
|
